1. Introduction
Tick-borne diseases (TBD) include a diverse group of clinical conditions caused by hemoparasites, viruses, and bacteria that affect hundreds of thousands of people worldwide [
1,
2]. In the Americas,
Rickettsia rickettsii spotted fever (RRSF) is the most severe of known spotted fever group rickettsioses (SFGR) [
3,
4,
5]. Clinical cases have been reported from Canada, the USA, Mexico, Costa Rica, Panama, Colombia, Brazil, and Argentina; and the disease is considered hyperendemic in some states of Mexico and Brazil [
3]. Historically, this disease has been known as Rocky Mountain Spotted Fever, although it has also taken on regional names such as Tobia Fever (Colombia) or Brazilian Spotted Fever (Brazil) [
5]. Throughout this distribution, genetic variability has been reported between
R. rickettsii strains from North America and those from Central and South America, with a higher number of polymorphisms observed in North America [
4,
5]. This variability may suggest a difference in virulence within each population, and a possible North American origin [
5]. In fact, there are avirulent (e.g. Iowa) and virulent (e.g. Shelia Smith) strains in North America, while Brazil, Colombia or Costa Rica only contain virulent strains (e.g. Taiacu); however, this may be a bias because the samples were obtained from patients [
5]. Furthermore, the recent descriptions of
R. rickettsii subspp.
californcia, and
Rickettsia lanei, a new species related to
R. rickettsii, raise new challenges in its taxonomy and in the ecoepidemiology of SFGR in the Americas [
6,
7], particularly regarding
R. rickettsii subspp.
Californica. This subspecies was described from
Dermacentor occidentalis isolates collected in California, USA [
6]. This strain was known as
Rickettsia species 364-D,
Rickettsia 364, or
Rickettsia philipii and causes a moderately severe disease in humans called Pacific Coast Tick Fever. It displays low virulence in guinea pigs and field mice in the laboratory; however, it is lethal in chicken embryos [
6].
Rickettsia lanei, isolated from
Haemaphysalis leporispalustris (USA), has demonstrated a close relationship with
R. rickettsii californica [
7].
Clinically, RRSF presents an acute febrile illness with severe headache and maculopapular or petechial rash, and many nonspecific symptoms such as myalgia, arthralgia, headache, dizziness, sore throat, diarrhea, photophobia, dysuria, and conjunctivitis [
1,
8,
9]. Progress of untreated infection causes damage to the endothelium of blood vessels and organs, and can lead to intravascular coagulopathies, or kidney, respiratory, heart, and nerve failure [
8,
9]. Treatment consists of doxycycline, another type of tetracycline or azithromycin; however, due to the severity of the disease, it is recommended to administer it in the first few days of care [
10]. In untreated cases, mortality can be high (20–70%), while patients recovering from severe forms of RRSF infection may experience hearing loss and mental disability, neurological and internal organ damage, or limb amputation [
3,
8].
Along with RRSF, other SFGR with similar symptoms and mild, moderate, or even severe clinical manifestations also reported in endemic areas for RRSF [
11]. In this regard, in the Americas there are reports of rash caused by
Rickettsia amblyommatis [
12], mild fevers with scar by
Rickettsia parkeri [
13,
14,
15], febrile cases caused by
Rickettsia massilliae [
16], and traveler rickettsiosis caused by
Rickettsia africae [
17,
18,
19]. Moreover, there are suspicions of RRSF in severe and fatal cases in all Central American countries [
20,
21]. Since some species of ticks are both vectors and reservoirs of RRSF, knowing the ecology of these vectors is a first step to understanding the epidemiology of these diseases.
As in other countries, RRSF is a disease with a low incidence in Panama, but with a high mortality rate. In the mid-20th century, five cases were reported, with two fatalities (mortality rate of 40%) [
10]. According to Calero et al. [
10], the recovery of 3 patients was due to the early suspicion of rickettsioses and timely treatment. A second peak of cases occurred from 2004 to 2024; 19laboratory-confirmed RRSF cases were identified, including 17 fatalities (mortality of 89%). In addition, 3 severe non-fatal SFGR cases were diagnosed using serological methods during the same period [
3,
22,
23]. Clinical cases of RRSF have been reported in both rural and urban areas which could lead to a wide spread of this disease.
The objective of this work is to present the clinical and epidemiological aspects of two new cases of SFGR, including another fatal RRSF case in Panama. These findings are presented and discussed in the context of the existing knowledge about the epidemiology of SFGR in Panama with an emphasis on existing gaps and future research directions to address this public health problem.
2. Case 1
On 25 July 2024, a 20-year-old male patient from Cutevilla (Llano del Norte, La Pintada, Coclé, Panamá) was presented at Centro de Salud de Coclesito (CSC, Colón, Panamá) with a 2-day history of fever, cephalea, vomiting, nasal congestion, rhinorrhea and hacking cough. On admission, physical evaluation revealed a normal constitution individual weighting 63.9 kg, his body temperature 38.4 °C, a heart rate of 116 bpm, a respiratory rate of 16 rpm, and oximetry with oxygen saturation of 99%. Detailed examination revealed hyaline rhinorrhea and hyperemia with a whitish pharyngotonsillar exudate on oropharyngeal examination and the remaining physical examination was normal. He was initially diagnosed with acute pharyngotonsillitis and prescribed amoxicillin at a dose of 500 mg three times a day for 7 days, along with paracetamol, ibuprofen, dimenhydrinate, and bromhexine, and discharged.
A day later, the patient returned to the same clinic with persistent vomiting and fever. At that time, he was febrile and had stable vital signs. He was prescribed 500 mL of intravenous Ringer’s lactate and routine laboratory tests (complete blood count and urinalysis), as well as dengue tests. He was advised to continue the prescribed medications and return to the clinic with the results of the lab tests prescribed.
On 27 July 2024, the patient returned due to persistent headache, repeated vomiting (3 or more episodes per day), and choluria. The patient denied bleeding or abdominal pain. The physical examination revealed a blood pressure 109/59 mmHg, a body temperature 38 °C, a heart rate 100 beats per min and a respiratory rate 18 breaths per min, and oxygen saturation of 99%. Laboratory results showed a hemoglobin level of 14.0 g/dL, a hematocrit of 42%, a total leukocyte count of 2.7 cells/mm3 (with a neutrophil differential of 77% and lymphocytes of 13%), and a platelet count of 49,000/uL. Urinalysis showed amber-colored urine, cloudy appearance, specific gravity of 1.030, pH 5, albumin 2+, erythrocytes 1 × HPF, leukocytes 7 x HPF, a fair number of epithelial cells, urate crystals 2+, bacteria: numerous, bile 2+, urobilinogen 2+, negative occult blood, and negative nitrites. One hour after his admission, the patient was transferred to the Hospital Aquilino Tejeira Hospital (HAT, Penonomé, Coclé province), with a suspicion of dengue fever with warning signs. Immunoserological tests for dengue were IgM negative and IgG positive; an NS1 antigen test was not performed.
In the HAT emergency room, the patient was treated with hydration and admitted to the medical ward on 28 July. He continued to experience osteomyalgia, nausea, and vomiting. He denied bleeding or other symptoms, and his oxygen saturation was 84%. Oxygen was administered at 4 L per min via nasal cannula. On the 29th, he continued to experience desaturation and tachycardia, along with increased abdominal pain.
On 30 July, the patient had a tonic–clonic seizure lasting approximately 2 min with sphincter relaxation. The patient became restless and responded to calls. His pupils were reactive to light; his oxygen saturation was 86% with 10 L per min oxygen supplied by a reservoir mask. He was afebrile, with capillary blood glucose levels 65 mg/dL, and Glasgow 11/15 (eye opening on verbal command, with incomprehensible sounds and motor movements on verbal command). His blood pressure was 140/80 mmHg, and his respiratory rate was 24 breaths per min. Phenytoin 1 gr, SSN, and ½ ampule of diazepam were administered intravenously over 30 min. On re-evaluation, the patient was less restless, saturating at 98%. Blood gas results were consistent with metabolic acidosis with elevated lactate: pH: 6.98, PCO2: 27, PO2: 51, Lactate: 17.1, HCO3: 6.6, Na: 131, K: 4.1. Then HCO3 #3 vials stat, D/SSN 850 mL + HCO3 #3 vials pp IV at 80 cc per h, amiodarone 150 mg IV stat, levofloxacin 750 mg IV stat, and antibiotics Meropenem + Vancomycin IV were administered. On 30 July, a chest X-ray revealed significant bilateral infiltrates. Intravenous furosemide and 150 mg of amiodarone were administered, and blood gases were analyzed after nebulization with Atrovent. Hantavirus infection or leptospirosis were suspected based on clinical manifestations. Next day in the morning, the patient went into cardiorespiratory arrest, and CPR was administered, and it was decided to secure the airway for transfer to a hospital with an intensive care unit. Direct laryngoscopy was performed, visualizing the glottis and vocal cords. The patient was intubated with a 7.5 ETT in one attempt, with no complications. The patient suffered three cardiopulmonary arrests for which advanced cardiopulmonary resuscitation was performed, with adrenaline administration. Transfer was arranged to the Rafael Estévez Hospital (Aguadulce, Coclé province), but the patient suffered a fourth cardiopulmonary arrest. After multiple efforts of resuscitation, the patient expired.
2.1. Laboratory Investigation
Postmortem samples of kidney, spleen, and liver were sent for diagnosis of
Hantavirus infection and leptospirosis, which were tested negative. DNA was extracted from necropsy specimens of kidney and spleen using the DNeasy tissue kit (Qiagen, Hilden, Germany), following the manufacturer’s instructions for tissue samples. Extracted DNA was tested by a battery of PCR protocols targeting
Rickettsia spp. using specific primers and published protocols for
gltA,
ompA, and
ompB genes [
23,
24]. In all PCR assays, distilled water was used as a negative control, and commercial
Rickettsia conorii strain (Vircell, Microbiologist) as a positive control. Positive samples were purified using ExoSap (USB) and sequenced with an automated sequencer (Applied Biosystems model ABI Prism 3130 × l Genetic, Foster City, CA, USA). DNA of
R. rickettsii was detected in kidney and spleen, amplicons had 99% sequences identity to
R. rickettsii Sheila Smith reference sequences to
gltA (GenBank CP000848.1), and 100% to
ompA (GenBank CP121767.1), and
ompB genes (GenBank CP000848.1). Partial
R. rickettsii gene sequences generated in this study are deposited in the GenBank database: spleen (
gltA: PX409978;
ompA: PX409980;
ompB: submitted); kidney (
gltA: PX409977;
ompA: PX409979;
ompB: PX409982).
2.2. Epidemiological and Ecological Investigation
The patient was a farmer that resided in a rural region on the border between the provinces of Coclé and Colón, at an altitude of approximately 100 m above sea level (masl). The main economic activity in this region is livestock farming, and a copper mine operates in the north of the region. The patient lived with his family (a woman and a 2-year-old child) in a concrete house with a zinc roof, equipped with a kitchen with a stove, electrical and sanitary services, and a shed in the backyard. The owners have two dogs from whom adult ticks were removed, and questing ticks were found on external walls and cement breeze blocks. All ticks were identified
Rhipicephalus sanguineus s.l. (31 larvae, 18 nymphs, 12 males, 19 females) using the taxonomic criteria of Bermúdez et al. [
21]. The patient worked on a farm near the home, where he stayed for several days. It was not possible to visit the area where the patient worked.
A case of RRSF was reported in this area in 2019, and other cases of this disease were reported in 2008 and 2017 in El Macano and El Valle of Anton, Coclé province (
Supplementary Material).
3. Case 2
On 22 February 2025 a 2-year-old boy from Llano Tugrí (Peña Blanca, Gnäbe Buglé indigenus comarca-GBIC) was admitted to Hospital Materno Infantil “José Domingo De Obaldía” (HMIJDDO), in David city, Chiriqui. This patient was transferred from Hospital Regional Chiriqui Este in San Félix, with a 7-day history of fever, headache, vomiting of food, dysuria, and watery, green, foul-smelling diarrhea, with no mucus, blood, or parasites. His mother reported that for the past day his legs had been “stiff” and that there were “bruises” in the abdominal area; in addition, the child experienced an episode of stiffness with “rolling eyes”, so he was taken to the health center, from where he was transferred to the hospital. The mother stated that the patient had no known medical history and denied respiratory symptoms or mentioned other sick people in the home and did not travel outside his community. The mother stated that the patient had no known medical history and denied respiratory symptoms or mentioned other sick people in the home.
During the consultation, the patient was intubated under sedation, and evidence of hypotension (a blood pressure 79/38 mmHg), cold, marbled skin, multiple petechiae, ecchymoses, and hematomas with a generalized distribution were evident, icteric tinge to the sclera, dry oral mucosa, with signs of bleeding, neck showed bilateral cervical lymphadenopathy, measuring <0.5 cm in diameter. The chest showed petechial lesions and hematomas. In addition, other observations included rhythmic heart, tachycardic, without murmurs or gallop; lung fields were bilaterally rough; abdomen showed purpuric lesions, soft, depressible, without rebound, and without visceromegaly; extremities showed hard edema of 2+, with a generalized petechial rash, predominantly on the thighs, which included involvement of the palms and soles, and capillary refill time was 3 s.
At the time of consultation, the patient presented with a body temperature of 38.8 °C. He was admitted on the same day in the Pediatric Intensive Care Unit (PICU) with diagnoses of septic shock, multiple organ failure, chronic malnutrition; dengue, leptospirosis, malaria, hemolytic uremic syndrome, Reye’s syndrome, and cholestatic syndrome were considered for differential diagnosis. The admission blood count revealed mild leukocytosis (13.5 × 103 cells/uL), moderate anemia (7.3 g/dL), and severe thrombocytopenia (9 × 103 cells/uL). Elevated transaminases alanine aminotransferase (ALT) at 68 U/L and aspartate aminotransferase (AST) at 190 U/L were observed. Cerebrospinal fluid showed no evidence of changes suggestive of infection. Imaging studies revealed no infiltrates or consolidations in chest X-ray. An abdominal ultrasound detected intestinal parasites and scant fluid in the flank and right iliac fossa. Retroperitoneal lymph nodes were not enlarged. Finally, a brain computed tomography scan revealed no signs of pathology, and an electroencephalogram showed no paroxysmal activity.
The patient was managed with advanced life support, antipyretics (acetaminophen), anticonvulsants (phenytoin, levetiracetam), antibiotic coverage (Ampicilina-sulbactam 450 mg iv c/6 h, Metronidazol 90 mg iv c/day, Cefepime 450 mg iv c/8 h, Cefotaxima 435 mg iv c/6 h, Clindamycin 120 mg iv c/8 h, Meropenem 370 mg iv c/8 h), as well as transfusions of cryoprecipitate, fresh frozen plasma, and packed red blood cells, and supportive care. Multiple platelet transfusions were required. Doxycycline 25 mg by nasogastric tube c/12 h treatment began on 24 February 2025 (2 days after admission). After sedation levels were lowered, a scheduled extubating was performed starting on 2 March 2025 (8 days after admission). The patient had a favorable clinical course, without seizures or fever, and was extubated on his ninth hospital day. He remained in the PICU for a total of 10 days and was subsequently transferred to the pediatric ward, where he completed the course of antibiotics and was assessed for his nutritional status until his discharge after 18 hospital days.
3.1. Laboratory Investigation
Samples to rule out dengue, Zika, Chikungunya, malaria, SARS-CoV-2, parvovirus B19, leptospirosis, viral hepatitis, cytomegalovirus, and Epstein–Barr virus infection were processed by the hospital laboratory; all tests were negative. To rule out rickettsial infection, immunofluorescence assay (IFA) for TGR and SFRG was performed, following the recommendations of the Focus Diagnostics® kit manufacturer (Cypress, CA, USA) that utilizes inactivated R. rickettsii and R. typhi antigens. Additionally, blood DNA extraction and PCR tests similar to those described in case 1 were performed. The results were positive for IgM-SFRG (IFA titer 1:256) and negative for IgM-TGR. No Rickettsia DNA was detected in the blood sample collected upon arrival at the hospital. On 10 March 2025, the patient blood was re-evaluated by IFA, resulting in 1/256 IgG antibody titter to SFRG.
3.2. Epidemiological and Ecological Investigation
The patient resides in a rural, mountainous region in GBIC, at an altitude of approximately 1700 masl. This area is connected by road to the Inter-American Highway. The patient’s home was evaluated by the Vector Control Unit, revealing block construction, a tile floor, a zinc roof, a stove-type kitchen, solar panel lighting, a septic tank, and waste management by incineration. The home is inhabited by 10 children and 5 adults. The father works on a coffee farm outside the comarca and had not been in contact with him or reported traveling outside their community for a month prior to the onset of symptoms, and his mother is a homemaker. No information was provided regarding the background of the tick bites. The owners have chickens and three dogs.
Adult and immature ticks were removed from the dogs, and identified as
Ixodes cf.
boliviensis,
Amblyomma ovale, and
Amblyomma mixtum using taxonomic criteria for adults [
25].
A. mixtum nymphs were identified by molecular methods [
26]. Ticks were analyzed following the method described above for the detection of
Rickettsia. All ticks were tested negative for
R. rickettsii DNA. This is the second episode of RRSF in GBIC, since the first outbreak occurred in 2019, when 6 people were affected and 4 died. This region is located approximately 940 m above sea level and lacks land routes (
Supplementary Material).
4. Epidemiological Review
To understand the epidemiology in Panama, a review of reported and published cases was conducted. Data of the confirmed and reported cases in Panama are shown in
Supplementary Material.
5. Discussion
5.1. Clinical Features
During the initial evaluation in both cases, the patients presented nonspecific symptoms such as fever, headache, vomiting, and gastrointestinal discomfort. In addition to these symptoms, the appearance of a skin rash in case 2 raised the diagnostic suspicion for RRSF. In both patients, the symptoms worsened as the disease progressed resulting in seizures and tachycardia. The initial suspicion in case 1 was a pharyngeal infection and dengue, another arboviral infection like Zika, Chikungunya or Oropuche virus, leptospirosis and
Hantavirus infection in both cases. These diseases are more prevalent in Panama; however, they were ruled out upon negative laboratory testing. These patients developed thrombocytopenia and leukocyte abnormalities, leukopenia (case 1) and leukocytosis (case 2), consistent with acute rickettsioses but not common for other diseases [
27,
28,
29,
30]. Furthermore, the elevated liver enzymes, metabolic acidosis, and pulmonary infiltrates seen in case 1 are consistent with the development of multiorgan failure and interstitial pneumonitis, and are signs of systemic damage and central nervous system disorders that provoked shock and death [
8,
27,
29,
30,
31]. The clinical description of cases in Panama was recently compiled [
31].
One aspect that stands out in these cases is that none of the cases reported or indicated contact with ticks, and in case 1 no petechiae or rash were reported. Regarding these, about 10% of patients do not develop petechiae or rash, and they are hardly distinguishable in dark-skinned people [
32,
33,
34]. The lack of a history of tick bites or the absence of petechiae cannot be a determining factor for including clinical suspicion and initiating treatment, since the patients with RRSF deteriorate rapidly, and the fatal cases are associated with lack of treatment with doxycycline or with untimely treatment.
According to Foley et al. [
3] most fatal cases of RRSF occur within the first 8 days of infection, providing a narrow therapeutic window. Some authors show that children, older adults, or people with comorbidities are among the highest risk groups [
35], therefore the initiation of treatment must be based on clinical suspicion, as in case 2 that had a satisfactory outcome due to the treatment [
10], which contrasts with the other case where the patient died [
24,
27,
36], even with doxycycline treatment [
37]. Although there is a guideline for the treatment of rickettsiosis in Panama [
38] and there are epidemiological data, clinical suspicion has not yet been established in many regions of the country. Cases not diagnosed in time may be considered medical negligence in this country [
39].
Since 2004, diagnosis has been based on serology by IFA, PCR, and sequencing and isolation (
Supplementary Material). IFA only allows the diagnosis of SFGR if there is evidence of IgM-IgG seroconversion in samples taken in the acute and convalescence phases but does not allow to determinate the
Rickettsia species unless multiple antigens are tested side-by-side and cross-absorption is performed to determine the etiological agent. In contrast, use of PCR and amplicon sequencing of
R. rickettsii DNA from blood and necropsy permitted reliable confirmation of RRSF in Panama (
Supplementary Material).
5.2. Epidemiological Challenges
Compared to other vector-borne diseases, the ecology of RRSF is complex and among the least understood, especially in Central America [
24]. This disease has been reported in different types of ecosystems from southern Canada to northern Argentina, involving several vector tick species, including endemic (
Amblyomma and
Dermacentor) and species introduced during the European conquest in America (
Rhipicephalus sanguineus complex) (
Table 1), in addition to an undetermined number of amplifying reservoirs that vary according to region. Risk factors for RRSF are related to exposure to infected ticks; hence, individuals who engage in outdoor activities or have pets are most vulnerable [
34,
40,
41,
42]. Since some tick species serve as both vectors and reservoirs of
R. rickettsii, knowing their ecology, phenology, and abundance is the first line of information needed to assess the risk of exposure in different parts of the country [
41,
43]. A second line of information may be the presence of vertebrates that serve as amplifier reservoirs to
R. rickettsii, information which is not available in most countries [
41,
42]. Thus, gaps of biological information constitute a challenge in many countries where updated tick lists are unavailable or where competent vectors have not been studied in the laboratory. However, the lack of this type of data should not diminish diagnostic suspicion in countries where cases have occurred.
In Panamá, the epidemiology of RRSF is not fully understood. In the last 21 years, cases have occurred upon contact with ticks in rural areas (13), urban and suburban locations (7), rural woodlands (2), and forests (1). Provinces with more cases are Panamá (with a family cluster of three cases), and Coclé and Colón, Panamá Oeste and GBIC, including a cluster of seven cases in 2019. Farmers and forest workers appear to have the highest risk of tick encounters; however, numbers of cases are linked to tick exposure in peridomestic rural and urban environments. The age of individuals diagnosed with RMSF in the last 20 years ranges from 2 years old to 60 years old, and most cases occur locally.
The first national serological survey in Panama was conducted in the mid-1950s, demonstrating a seropositivity rate of between 5% and 15% in a sample of 1400 volunteers [
59]. In 2013, a seroprevalence study was conducted among people who handled wild and domestic animals, of 97 healthy volunteers from the communities of Tortí (Darién province), Parque Municipal Summit (Panama province), and El Valle de Antón (Coclé province), 38 (39%) IgG-type antibodies to SFGR using inactivated
R. rickettsii and
R. typhi antigens [
60]. An animal survey detected IgG antibodies reacting to
R. rickettsii antigen in dogs and horses from El Valle de Antón [
61], and synanthropic mammals as such opossums and a coyote in Panama and Panama Oeste provinces [
62]. Several species and unnamed isolates of SFGR have been identified in many tick species collected in Panama [
2]. These data demonstrate the circulation of SFGR among ticks and animals in several locations in Panama and that people have contacts with
Rickettsia-infected ticks, including areas where cases have been reported. A molecular survey of wildlife and peridomestic animals should be conducted to determine the circulation of
R. rickettsii or to establish which animals could be amplifying reservoirs.
Amblyoma mixtum and
R. sanguineus s.l. are viewed as most likely vectors of
R. rickettsii in Panama—both ticks have a broad area of distribution across the country [
10,
24,
53,
54,
63,
64]; however, their vector competence is not fully evaluated.
Amblyomma mixtum is found mainly in lowlands (below 1000 masl) in the Pacific Basin, persisting in grazing areas, riparian, and secondary forests;
R. sanguineus s.l. is an intra-domiciliary tick species found in urban, suburban, and rural dwellings [
54,
64,
65]. The distribution areas of both ticks overlap with the geography of 47% of RRSF and SFGR cases, which exclude those from wild areas (absence of
R. sanguineus s.l.) and urban (absence of
A. mixtum). Moreover, tick distribution overlaps with the distribution of vectors of more prevalent pathogens, especially
Aedes and other mosquitoes (urban and rural environments), and with diseases such as leptospirosis (rural environments), in addition to other pathologies such as SARS-CoV-2, parvovirus B19, viral hepatitis, and cytomegalovirus [
66,
67,
68,
69].
The majority of RRSF cases in Panama occurring in rural settings are concordant with the presence of
A. mixtum, which is an eclectic species [
54,
64]. RRSF eco-epidemiology associated with
Amblyomma cajennense complex ticks is complex, as it involves multiple species of potential amplifying reservoirs. In Brazil,
Amblyomma sculptum, another species of the
A. cajennense complex, parasitizes several species of mammals and it has been recognized that the capybara (
Hydrochoerus hydrochaeris) serves as amplifying reservoirs of
R. rickettsii [
41]. Although in Panama the related species
Hydrochoerus isthmius is a host of
A. mixtum [
70], its susceptibility to
R. rickettsii has not been studied; however, this rodent species only inhabits the eastern portion of Panama and, to date, no cases have been confirmed in that region. This represents that most cases that are assumed to be related to
A. mixtum must have another mammal species as a reservoir. Although horses are common hosts of
A. mixtum in Panama [
69,
70], their role as amplifiers of
R. rickettsii has not been demonstrated. Another scenario would suggest that it may be associated with
R. sanguineus s.l. infesting homes in urbanized settlements, with dogs as putative reservoirs. Since
R. rickettsii can cause disease in dogs [
47], it is necessary to establish measures to separate its symptoms from those of canine ehrlichiosis, another disease transmitted by
R. sanguineus s.l.
Regarding the current cases, despite
R. rickettsii not being detected in the ticks analyzed from both cases, the presence of
A. mixtum in GBIC at 1700 masl and in a locality of SFGR could indicate a new ecological scenario for these diseases, associated with a more temperate climate. In 2019, an RRSF family cluster moved to another town in GBIC. Given this, more data is needed to confirm vectors in regional areas, particularly because the patient is a young child and
A. mixtum is not an intra-domiciliary species. Even so, the existence of foreign species such as
Dermacentor andersonii or
Dermacentor variabilis can be ruled out as a vector in Panama [
71]. The failure to find
R. rickettsii in ticks is not unusual, as low infection rates have been reported in tick populations in RRSF-endemic areas [
72]. However, unlike the present case, the majority were people who were able to travel from other locations, while the patient’s mother reported no movement prior to the onset of symptoms.
6. Conclusions
RRSF is an epidemiologically complex disease that puts its sufferers at risk of death; therefore, early diagnostic suspicion is required to enable appropriate treatment within the first few days after the onset of symptoms. Even when this disease has a low prevalence, and epidemiological information is lacking, it should be included in the diagnostic suspicion for patients presenting with fever, malaise, thrombocytopenia, leukopenia, or altered liver enzyme levels, which suggest diseases that have a higher incidence, such as dengue and other arboviral infections, malaria, and leptospirosis, among others. In Panama and other countries in the region, studies should be established that integrate the distribution and ecology of its potential vectors to develop specific prevention programs in endemic regions, especially considering that the ecoepidemiology of SFGR varies from one region to another [
52]. Finally, future research could evaluate the genetic variability of
R. rickettsii in Central America, especially considering the recent descriptions of
R. lanei and
R. rickettsii californica [
6,
7,
52].
Author Contributions
Conceptualization, S.B., E.F.A. and N.A.; methodology, A.M., A.P., Y.Z., M.H., L.D., J.O.C., B.G., D.E., M.H., S.B., N.A., F.S. and E.F.A.; validation, S.B., E.F.A., N.A., K.B. and D.E.; formal analysis, F.S., A.M.-C., A.P., M.H. and S.B.; investigation, S.B., E.F.A., N.A., B.G., D.E. and K.B.; data curation, S.B. and F.S.; writing—original draft preparation, S.B., E.F.A. and N.A.; writing—review and editing, S.B., E.F.A., N.A., M.H., B.G., L.D., C.G., J.O.C., Y.Z., A.M.-C., A.M., M.M.-M., A.P., D.E., K.B. and F.S. All authors have read and agreed to the published version of the manuscript.
Funding
This research received no external funding.
Institutional Review Board Statement
The use of the data was authorized by 196-RSC-SFCRH-2025 (HAT) (approval date: 22 July 2025), UE-38-2025 (HMIJDDO) (4 August 2025).
Informed Consent Statement
Written informed consent was obtained from the patient to publish this paper.
Data Availability Statement
The original contributions presented in this study are included in the article/
Supplementary Material. Further inquiries can be directed to the corresponding authors.
Acknowledgments
We thank Candelario Olivares and Ramón Trujillo (Vector Control, Coclé) for their logistical support; and Andrew Quitmeyer and Hubert Herz for helping prepare the original draft. We especially thank Marina Eremeeva (Georgia Southern University, Statesboro, GA, USA) for her advice and improvements in writing the manuscript.
Conflicts of Interest
The authors declare no conflicts of interest.
Abbreviations
The following abbreviations are used in this manuscript:
CSC | Centro de Salud de Coclesito |
GBIC | Gnäbe Buglé Indigenous Comarca |
HAT | Hospital Aquilino Tejera |
HMIJDDO | Hospital Materno Infantil “José Domingo De Obaldía” |
IFA | Immunofluorescence Assay |
SFGR | Spotted Fever Group Rickettsia |
RRSF | Rickettsia rickettsii Spotted Fever |
TBD | Tick-borne Disease |
References
- Dixon, D.M.; Branda, J.A.; Clark, S.H.; Dumler, J.S.; Horowitz, H.W.; Perdue, S.S.; Pritt, B.S.; Sexton, D.J.; Storch, G.A.; Walker, D.H. Ehrlichiosis and Anaplasmosis subcommittee report to the tick-borne disease working group. Ticks Tick-Borne Dis. 2021, 12, 101823. [Google Scholar] [CrossRef]
- de la Fuente, J.; Estrada-Peña, A.; Rafael, M.; Almazán, C.; Bermúdez, S.; Abdelbaset, A.E.; Kasaija, P.D.; Kabi, F.; Akande, F.A.; Ajagbe, D.O.; et al. Perception of ticks and tick-borne diseases Worldwide. Pathogens 2024, 12, 1258. [Google Scholar] [CrossRef] [PubMed]
- Foley, J.; López-Pérez, A.M.; Álvarez-Hernández, G.; Labruna, M.B.; Angerami, R.N.; Zazueta, O.E.; Bermudez, S.; Rubino, F.; Salzer, J.S.; Brophy, M.; et al. A wolf at the door: The ecology, epidemiology, and emergence of community- and urban-level Rocky Mountain spotted fever in the Americas. Am. J. Vet. Res. 2025, 86, ajvr.24.11.0368. [Google Scholar] [CrossRef] [PubMed]
- Eremeeva, M.E.; Dasch, G.A. Closing the gaps between genotype and phenotype in Rickettsia rickettsii. Ann. N. Y. Acad. Sci. 2009, 1166, 12–26. [Google Scholar] [CrossRef]
- Labruna, M.B.; Santos, F.C.; Ogrzewalska, M.; Nascimento, E.M.; Colombo, S.; Marcili, A.; Angerami, R.N. Genetic identification of Rickettsial isolates from fatal cases of Brazilian spotted fever and comparison with Rickettsia rickettsii isolates from the American continents. J. Clin. Microbiol. 2014, 52, 3788–3791. [Google Scholar] [CrossRef]
- Paddock, C.D.; Karpathy, S.E.; Henry, A.; Ryle, L.; Hecht, J.A.; Hacker, J.K.; Padgett, K.A.; Kjemtrup, A.M.; Bullock, H.; Lane, R.S.; et al. Rickettsia rickettsii subsp californica subsp nov, the etiologic agent of Pacific Coast Tick Fever. J. Infect. Dis. 2025, 231, 849–858. [Google Scholar] [CrossRef]
- Paddock, C.D.; Harris, A.; Clark, T.R.; Bullock, H.A.; Hecht, J.A.; Ladner, J.T.; Karpathy, S.E. Rickettsia lanei, sp. nov. (Rickettsiales: Rickettsiaceae), a newly recognized pathogen of humans associated with the rabbit tick, Haemaphysalis leporispalustris (Acari: Ixodidae). Am. J. Trop. Med. Hyg. 2025, 250134. [Google Scholar] [CrossRef]
- Valbuena, G. Patogénesis de las rickettsioses en las Américas. Rev. MVZ 2010, 15, 2004–2006. [Google Scholar]
- Álvarez-Hernández, G.; Roldán, J.F.G.; Milan, N.S.H.; Lash, R.R.; Behravesh, C.B.; Paddock, C.D. Rocky Mountain spotted fever in Mexico: Past, present, and future. Lancet Infect. Dis. 2017, 17, e189–e196. [Google Scholar] [CrossRef]
- Calero, C.; Nuñez, J.; Silva-Goytía, R. Rocky Mountain spotted fever in Panama; report of two cases. Am. J. Trop. Med. Hyg. 1952, 1, 631–636. [Google Scholar] [CrossRef] [PubMed]
- Eremeeva, M.; Dasch, G. Challenges posed by tick-borne rickettsiae: Eco-epidemiology and public health implications. Front. Public Health 2015, 3, 55. [Google Scholar] [CrossRef] [PubMed]
- Billeter, S.; Blanton, H.; Little, S.; Levy, M.; Breitschwerdt, E. Detection of Rickettsia amblyommii in association with a tick bite rash. Vector Borne Zoonotic Dis. 2007, 7, 607–610. [Google Scholar] [CrossRef]
- Paddock, C.D.; Sumner, J.W.; Comer, J.A.; Zaki, S.R.; Goldsmith, C.S.; Goddard, J.; McLellan, S.L.; Tamminga, C.L.; Ohl, C.A. Rickettsia parkeri: A newly recognized cause of spotted fever rickettsioses in the United States. Clin. Infect. Dis. 2004, 38, 805–811. [Google Scholar] [CrossRef]
- Romer, Y.; Seijo, A.C.; Crudo, F.; Nicholson, W.L.; Varela-Stokes, A.; Lash, R.R.; Paddock, C.D. Rickettsia parkeri rickettsioses, Argentina. Emerg. Infect. Dis. 2011, 17, 1169–1173. [Google Scholar] [CrossRef] [PubMed]
- Silva-Ramos, C.; Hidalgo, M.; Faccini-Martínez, Á. Clinical, epidemiological, and laboratory features of Rickettsia parkeri rickettsioses: A systematic review. Ticks Tick Borne Dis. 2021, 12, 101734. [Google Scholar] [CrossRef]
- García-García, J.C.; Portillo, A.; Núñez, M.J.; Santibáñez, S.; Castro, B.; Oteo, J.A. Case report: A patient from Argentina infected with Rickettsia massilliae. Am. J. Trop. Hyg. 2010, 82, 691–692. [Google Scholar] [CrossRef]
- Kelly, P. Rickettsia africae in the West Indies. Emerg. Infect. Dis. 2006, 12, 224–226. [Google Scholar] [CrossRef]
- Armitano, R.; Borras, P.; Govedic, F.; Prieto, M.; Guillemi, E. African Tick Bite Fever: First imported cases diagnosed by PCR in Argentina. Travel Med. Infect. Dis. 2021, 40, 101959. [Google Scholar] [CrossRef] [PubMed]
- Silva-Ramos, C.; Bernal-García, E.; Gómez, M.; Gil-Mora, J. First case of Rickettsia africae rickettsioses, African tick-bite fever, in a Colombian traveler. Travel Med. Infect. Dis. 2022, 50, 102463. [Google Scholar] [CrossRef]
- Labruna, M.; Mattar, S.; Nava, S.; Bermúdez, S.E.; Venzal, J.; Dolz, G.; Abarca, K.; Romero, L.; de Souza, K.; Oteo, J.; et al. Rickettsioses in Latin America, Caribbean, Spain and Portugal. Rev. Med. Vet. Zootec. 2011, 16, 2435–2457. [Google Scholar] [CrossRef]
- Bermúdez, S.; Troyo, A. A review of the genus Rickettsia in Central America. Res. Rep. Trop. Med. 2018, 9, 103–112. [Google Scholar] [CrossRef]
- De Lucas, J.; García, E.; García, G.; Castro, A.; Lyon, C.; Bermúdez, S. Nuevo caso de rickettsioses humana en Panamá, a partir de evidencia serológica y clínica. Rev. Med. Pan. 2013, 34, 40–43. [Google Scholar]
- Zaldívar, Y.; Hernández, M.; Domínguez, L.; Saénz, L.; Montilla, S.; de Antinori, M.E.B.; Krawczak, F.S. Isolation of Rickettsia rickettsii from an outbreak of Rocky Mountain spotted fever in Panama. Emerg. Infect. Dis. 2021, 27, 1244–1246. [Google Scholar] [CrossRef] [PubMed]
- Martínez-Caballero, A.; Moreno, B.; González, C.; Martínez, G.; Adames, M.; Pachar, J.V.; Varela-Petrucelli, J.B.; Martínez-Mandiche, J.; Domínguez, L. Descriptions of two new cases of Rocky Mountain spotted fever in Panama, and coincident infection with Rickettsia rickettsii in Rhipicephalus sanguineus s.l. in an urban locality of Panama City, Panama. Epidemiol. Infect. 2018, 146, 875–878. [Google Scholar] [CrossRef] [PubMed]
- Bermúdez, S.; Domínguez, L. Garrapatas. In Importancia Médica de la Flora y Fauna Panameña; Senacyt: Ciudad de Panamá, Panamá, 2019; pp. 195–203. ISBN 978-9962-680-19-2. [Google Scholar]
- Mangold, A.; Bargues, M.; Mas-Coma, S. Mitochondrial 16S rDNA sequences and phylogenetic relationships of species of Rhipicephalus and other tick genera among Metastriata (Acari: Ixodidae). Parasitol. Res. 1998, 84, 478–484. [Google Scholar] [CrossRef]
- Estripeaut, D.; Aramburú, M.G.; Sáez-Llorens, X.; Thompson, H.A.; Dasch, G.A.; Paddock, C.D.; Zaki, S.; Eremeeva, M.E. Rocky Mountain spotted fever, Panama. Emerg. Infect. Dis. 2007, 13, 1763–1765. [Google Scholar] [CrossRef] [PubMed]
- Hidalgo, M.; Orejuela, L.; Fuya, P.; Carrillo, P.; Hernandez, J.; Parra, E.; Keng, C.; Small, M.; Olano, J.P.; Bouyer, D. Rocky Mountain spotted fever, Colombia. Emerg. Infect. Dis. 2007, 13, 1058–1060. [Google Scholar] [CrossRef]
- Zazueta, O.E.; Armstrong, P.A.; Márquez-Elguea, A.; Hernández Milán, N.S.; Peterson, A.E.; Ovalle-Marroquín, D.F.; Fierro, M.; Arroyo-Machado, R.; Rodriguez-Lomeli, M.; Trejo-Dozal, G. Rocky Mountain Spotted Fever in a Large Metropolitan Center, Mexico-United States Border, 2009–2019. Emerg. Infect. Dis. 2021, 27, 1567–1576. [Google Scholar] [CrossRef]
- Kamper, C.; Chessman, K.; Phelps, S. Rocky Mountain spotted fever. Clin. Pharm. 1988, 7, 109–116. [Google Scholar]
- Daza, C.; Bermúdez, S. Características clínicas y para clínicas de los pacientes con fiebre manchada por Rickettsia rickettsii en Panamá (1950–1951; 2004–2017). Rer. Méd. Pan. 2019, 39, 79–84. [Google Scholar]
- Dantas-Torres, F. Rocky Mountain spotted fever. Lancet Infect. Dis. 2007, 7, 724–732. [Google Scholar] [CrossRef]
- McCollough, M. RMSF and Serious Tick-Borne Illnesses (Lyme, Ehrlichiosis, Babesiosis and Tick Paralysis). Life-Threat. Rashes 2018, 12, 215–240. [Google Scholar] [CrossRef]
- Paddock, C.; Alvarez-Hernández, G. Rickettsia rickettsii (Rocky Mountain Spotted Fever). In Principles and Practice of Pediatric Infectious Diseases; Elsevier Inc.: Amsterdam, The Netherlands, 2018; pp. 952–957.e2. [Google Scholar] [CrossRef]
- Álvarez-Hernández, G.; Rivera-Rosas, C.; Calleja-López, J. La fiebre manchada por Rickettsia rickettsii es una enfermedad desatendida. Sal. Pub. Mex. 2024, 66, 321. [Google Scholar] [CrossRef] [PubMed]
- Tribaldos, M.; Zaldívar, Y.; Bermúdez, S.; Samudio, F. Rocky Mountain spotted fever in Panama: A cluster description. J. Infect. Dev. Ctries. 2011, 5, 737–741. [Google Scholar] [CrossRef] [PubMed]
- Linero, K.; Serrano, S.; Florian, D. Rickettsioses: La importancia de realizar un diagnóstico precoz y manejo temprano. Pediatr. Panamá 2022, 51, 30–38. [Google Scholar] [CrossRef]
- Anonymous. Guía para al Abordaje Clínico y Epidemiológico de las Rickettsioses en Panamá, Gaceta Oficial Digital No. 28852; Gobierno de la República de Panamá: Ciudad de Panamá, Panamá, 2019. [Google Scholar]
- Pachar-Lucio, J.; Ruiz-Arango, J.; Bermúdez-Castillero, S.; Rodríguez de Pachar, G. Muerte inesperada por rickettsioses: Implicaciones médico-legales y epidemiológicas. Colom. For. 2017, 4, 91–98. [Google Scholar] [CrossRef]
- Silveira, I.; Martins, T.F.; Olegário, M.M.; Peterka, C.; Guedes, E.; Ferreira, F. Labruna MB.Rickettsial infection in animals, humans and ticks in Paulicéia, Brazil. Zoon. Pub. Health 2015, 62, 525–533. [Google Scholar] [CrossRef]
- Szabó, M.; Pinter, A.; Labruna, M. Ecology, biology and distribution of spotted-fever tick vectors in Brazil. Front. Cell. Infect. Microbiol. 2013, 3, 27. [Google Scholar] [CrossRef]
- Álvarez-López, D.I.; Ochoa-Mora, E.; Nichols Heitman, K.; Binder, A.M.; Álvarez-Hernández, G.; Armstrong, P.A. Epidemiology and clinical features of Rocky Mountain Spotted Fever from enhanced surveillance, Sonora, Mexico: 2015–2018. Am. J. Trop. Med. Hyg. 2021, 104, 190–197. [Google Scholar] [CrossRef]
- Biggs, H.M.; Behravesh, C.B.; Bradley, K.K.; Dahlgren, F.S.; Drexler, N.A.; Dumler, J.S.; Folk, S.M.; Kato, C.Y.; Lash, R.R.; Levin, M.L. Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain Spotted fever and other spotted fever group rickettsioses, ehrlichioses, and anaplasmosis, United States. Morb. Mortal. Wkly. Rep. 2016, 65, 1–44. [Google Scholar] [CrossRef]
- Tarragona, E.L.; Soares, J.F.; Costa, F.B.; Labruna, M.B.; Nava, S. Vectorial competence of Amblyomma tonelliae to transmit Rickettsia rickettsii. Med. Vet. Entomol. 2016, 30, 410–415. [Google Scholar] [CrossRef] [PubMed]
- Binder, L.C.; Fanchini, C.E.C.; Soares, H.S.; Martins, M.P.; Silito, I.S.; Labruna, M.B. Vector competence and transovarial transmission of Rickettsia rickettsii in Rickettsia bellii-infected and -uninfected Amblyomma dubitatum ticks. Exp. Appl. Acarol. 2025, 95, 3. [Google Scholar] [CrossRef] [PubMed]
- Costa, F.B.; Gerardi, M.; Binder, L.C.; Benatti, H.R.; Serpa, M.C.A.; Lopes, B.; Luz, H.R.; Ferraz, K.M.P.M.B.; Labruna, M.B. Rickettsia rickettsii (Rickettsiales: Rickettsiaceae) infecting Amblyomma sculptum (Acari: Ixodidae) ticks and capybaras in a Brazilian Spotted Fever-Endemic Area of Brazil. J. Med. Entomol. 2020, 57, 308–311. [Google Scholar] [CrossRef]
- Piranda, E.M.; Faccini, J.L.; Pinter, A.; Pacheco, R.C.; Cançado, P.H.; Labruna, M.B. Experimental infection of Rhipicephalus sanguineus ticks with the bacterium Rickettsia rickettsii, using experimentally infected dogs. Vector Borne Zoonotic Dis. 2011, 11, 29–36. [Google Scholar] [CrossRef]
- Warner, R.D.; Marsh, W.W. Rocky Mountain spotted fever. J. Am. Vet. Med. Assoc. 2002, 221, 1413–1417. [Google Scholar] [CrossRef] [PubMed]
- Martínez-Diaz, H.C.; Forero-Becerra, E.; Hidalgo, M.; Labruna, M.B. Experimental infection and vector competence of Amblyomma patinoi, a member of the Amblyomma cajennense species complex, for the human pathogen Rickettsia rickettsii. Ticks Tick Borne Dis. 2021, 12, 101751. [Google Scholar] [CrossRef]
- Eremeeva, M.E.; Zambrano, M.L.; Anaya, L.; Beati, L.; Karpathy, S.E.; Santos-Silva, M.M.; Salceda, B.; MacBeth, D.; Olguin, H.; Dasch, G.A.; et al. Rickettsia rickettsii in Rhipicephalus ticks, Mexicali, Mexico. J. Med. Entomol. 2011, 48, 418–421. [Google Scholar] [CrossRef]
- Levin, M.L.; Zemtsova, G.E.; Killmaster, L.F.; Snellgrove, A.; Schumacher, L.B.M. Vector competence of Amblyomma americanum (Acari: Ixodidae) for Rickettsia rickettsii. Ticks Tick Borne Dis. 2017, 8, 615–622. [Google Scholar] [CrossRef]
- Paddock, C.D.; Denison, A.M.; Lash, R.R.; Liu, L.; Bollweg, B.C.; Dahlgren, F.S.; Kanamura, C.T.; Angerami, R.N.; Pereira dos Santos, F.C. Phylogeography of Rickettsia rickettsii genotypes associated with fatal Rocky Mountain spotted fever. Am. J. Trop. Med. Hyg. 2014, 91, 589–597. [Google Scholar] [CrossRef]
- de Rodaniche, E. Natural infection of the tick, Amblyomma cajennense, with Rickettsia rickettsii in Panama. Am. J. Trop. Med. Hyg. 1953, 2, 696–699. [Google Scholar] [CrossRef]
- Bermúdez, S.E.; Castro, A.M.; Trejos, D.; García, G.G.; Gabster, A.; Miranda, R.J.; Zaldívar, Y.; Paternina, L.E. Distribution of spotted fever group Rickettsiae in hard ticks (Ixodida: Ixodidae) from Panamanian urban and rural environments. EcoHealth 2017, 13, 274–284. [Google Scholar] [CrossRef]
- Sánchez-Montes, S.; Colunga-Salas, P.; Lozano-Sardaneta, Y.N.; Zazueta-Islas, H.M.; Ballados-González, G.G.; Salceda-Sánchez, B.; Huerta-Jiménez, H.; Torres-Castro, M.; Panti-May, J.A.; Peniche-Lara, G.; et al. The genus Rickettsia in Mexico: Current knowledge and perspectives. Ticks Tick Borne Dis. 2021, 12, 101633. [Google Scholar] [CrossRef]
- Fuentes, L.; Calderón, A.; Hun, L. Isolation and identification of Rickettsia rickettsii from the rabbit tick Haemaphysalis leporispalustris in the Atlantic zone of Costa Rica. Am. J. Trop. Med. Hyg. 1985, 34, 564–567. [Google Scholar] [CrossRef]
- Troyo, A.; Moreira-Soto, R.D.; Calderon-Arguedas, Ó.; Mata-Somarribas, C.; Ortiz-Tello, J.; Barbieri, A.R.; Avendaño, A.; Vargas-Castro, L.E.; Labruna, M.B.; Hun, L.; et al. Detection of rickettsiae in fleas and ticks from areas of Costa Rica with history of spotted fever group rickettsioses. Ticks Tick Borne Dis. 2016, 7, 1128–1134. [Google Scholar] [CrossRef]
- Bermúdez, S.E.; Eremeeva, M.E.; Karpathy, S.E.; Samudio, F.; Zambrano, M.L.; Zaldivar, Y.; Motta, J.A.; Dasch, G.A. Detection and identification of rickettsial agents in ticks from domestic mammals in eastern Panama. J. Med. Entomol. 2009, 46, 856–861. [Google Scholar] [CrossRef]
- Silva-Goytia, R.; Calero, C. Estudio sobre fiebre manchada, fiebre Q y tifus exantemático en el istmo de Panamá. Arch. Med. Panam. 1956, 5, 99–106. [Google Scholar]
- Bermúdez, S.E.; Lyons, C.R.; García, G.G.; Zaldíva, Y.L.; Gabster, A.; Arteaga, G.B. Serologic evidence of human Rickettsia infection found in three locations in Panama. Rev. Biomed. 2013, 33, 31–37. [Google Scholar] [CrossRef]
- Bermúdez, C.S.; Zaldívar, A.Y.; Spolidorio, M.G.; Moraes-Filho, J.; Miranda, R.J.; Caballero, C.M.; Mendoza, Y.; Labruna, M.B. Rickettsial infection in domestic mammals and their ectoparasites in El Valle de Antón, Coclé, Panamá. Vet. Parasitol. 2011, 177, 134–138. [Google Scholar] [CrossRef] [PubMed]
- Bermúdez, S.E.; Gottdenker, N.; Krishnvajhala, A.; Fox, A.; Wilder, H.K.; González, K.; Smith, D.; López, M.; Perea, M.; Rigg, C.; et al. Synanthropic mammals as potential hosts of tick-borne pathogens in Panama. PLoS ONE 2017, 12, e0169047. [Google Scholar] [CrossRef]
- Bermúdez, S.; Zieman, E.; Tarragona, E.; Martins, T.; Faccini-Martínez, A.; Thomas, R.; Guzmán-Cornejo, C.; Muñoz-Leal, S. Tick-Borne microorganisms in Neotropical vertebrates. In Ecology of Wildlife Diseases in the Neotropics; Acosta-Jammet, G., Chavez, A., Eds.; Springer: Cham, Switzerland, 2024; 412p. [Google Scholar] [CrossRef]
- Fairchild, G.; Kohls, G.; Tipton, J. The ticks of Panama (Acarina: Ixodoidea). In Ectoparasites of Panama; Wenzel, R.L., Tipton, V.J., Eds.; Field Museum of Natural History: Chicago, IL, USA, 1966; pp. 167–207. [Google Scholar]
- Bermúdez, S.; Miranda, R. Distribution of ectoparasites of Canis lupus familiaris L. (Carnivora: Canidae) from Panama. Rev. Med. Vet. Zoon. 2011, 16, 2274–2282. [Google Scholar]
- Carrera, J.P.; Díaz, Y.; Denis, B.; Barahona de Mosca, I.; Rodriguez, D.; Cedeño, I.; Arauz, D.; González, P.; Cerezo, L.; Moreno, L. Unusual pattern of chikungunya virus epidemic in the Americas, the Panamanian experience. PLoS Negl. Trop. Dis. 2017, 11, e0005338. [Google Scholar] [CrossRef] [PubMed]
- Hurtado, L.; Cumbrera, A.; Rigg, C.; Perea, M. Long-term transmission patterns and public health policies leading to malaria elimination in Panamá. Malar. J. 2020, 19, 265. [Google Scholar] [CrossRef] [PubMed]
- Vazquez Guillamet, L.J.; Arauz, A.B.; Suárez, J.A.; González, E.; Domingo de Obaldía, J.; Moreno, D.; Henostroza, G.; Armién, B. Leptospirosis: Epidemiological and Clinical Characteristics at the National Reference Hospital in Panama. Am. J. Trop. Med. Hyg. 2022, 107, 1261–1266. [Google Scholar] [CrossRef] [PubMed]
- Chen-Germán, M.; Araúz, D.; Aguilar, C.; Vega, M.; Gonzalez, C.; Gondola, J.; Moreno, L.; Cerezo, L.; Franco, L.; Mendez-Rico, J. Detection of dengue virus serotype 4 in Panama after 23 years without circulation. Front. Cell. Infect. Microbiol. 2024, 14, 1467465. [Google Scholar] [CrossRef]
- García, G.; Castro, A.; Rodríguez, I.; Bermúdez, S. Ixodid ticks of Hydrochoerus isthmius Goldman 1912 (Rodentia: Caviidae) in Panama. Syst. Appl. Acarol. 2014, 19, 404–408. [Google Scholar] [CrossRef]
- Daza, T.C.A.; Estripeaut, D.; Morales, M.S.; Sánchez, A.R.; González, A.; Hernández, M.; Zaldívar, Y.; Poveda, Á.; Martínez-Monter, M.; Guenther, E.; et al. Clinical manifestations of Rickettsia rickettsii in a familial outbreak in Panama. Travel Med. Infect. Dis. 2023, 52, 102542. [Google Scholar] [CrossRef]
- Ribeiro, C.M.; Carvalho, J.L.B.; Bastos, P.A.S.; Katagiri, S.; Batalha, E.Y.; Okano, W.; Costa, V.M.D. Prevalence of Rickettsia rickettsii in Ticks: Systematic Review and Meta-Analysis. Vector Borne Zoonotic Dis. 2021, 21, 557–565. [Google Scholar]
Table 1.
Ticks related to Rickettsia rickettsii according to vector competence or natural infection.
Table 1.
Ticks related to Rickettsia rickettsii according to vector competence or natural infection.
Competent Vectors a | Country | Genus | Species | References |
---|
| Argentina | Amblyomma | tonelliae | [44] |
| Brazil | Amblyomma | dubitatum | [45] |
| Brazil | Amblyomma | sculptum | [46] |
| Brazil | Rhipicephalus | sanguineus s.l. | [47] |
| Canada | Dermacentor | andersonii | [48] |
| Canada | Dermacentor | variabilis | [48] |
| Colombia | Amblyomma | patinoi | [49] |
| Mexico | Rhipicephalus | sanguineus s.s. | [50] |
| USA | Amblyomma | americanum | [51] |
| USA | Dermacentor | andersonii | [48] |
| USA | Dermacentor | variabilis | [48] |
| USA | Dermacentor | occidentalis | [52] |
Potential vectors b | Panama | Amblyomma | mixtum | [53,54] |
| Panama | Rhipicephalus | sanguineus s.l. | [10,24] |
No evidence of vector capacity c | Mexico | Amblyomma | americanum | [55] |
| Mexico | Amblyomma | maculatum | [55] |
| Mexico | Amblyomma | cf. parvum | [55] |
| Mexico | Amblyomma | tenellum | [55] |
| Mexico | Dermacentor | nitens | [55] |
| Mexico | Ornithodoros | nicollei | [55] |
| Mexico | Otobius | lagophilus | [55] |
| Costa Rica | Haemaphysalis | leporispalustris | [56] |
| Costa Rica | Amblyomma | varium | [57] |
| Costa Rica | Amblyomma | mixtum | [57] |
| Panama | Dermacentor | nitens | [58] |
| Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).